Home

Martin Auster

CIK 1875786 · CHIEF FINANCIAL OFFICER · last filed 2024-04-03

Martin Auster is a CHIEF FINANCIAL OFFICER who has filed 17 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing shows the insider sold $7.6K of VTYX on Apr 3, 2024. Across all open-market trades the lifetime net is −$7.6M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

17

Lifetime Open-Market Net

-$7.61M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Ventyx Biosciences, Inc. (VTYX) Delisted CHIEF FINANCIAL OFFICER 24,303 $13.99 $340.0K -$7.61M 13 2024-04-03

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-04-03 Ventyx Biosciences, Inc. (VTYX) Delisted Sell (S) −1,405 -$7.6K EDGAR
2024-04-02 Ventyx Biosciences, Inc. (VTYX) Delisted Notice (144) −1,405 -$7.6K EDGAR
2024-03-29 Ventyx Biosciences, Inc. (VTYX) Delisted Exer (M) +4,531 $0 EDGAR
2024-01-03 Ventyx Biosciences, Inc. (VTYX) Delisted Grant (A) — $0 EDGAR
2023-12-19 Ventyx Biosciences, Inc. (VTYX) Delisted Grant (A) — $0 EDGAR
2023-09-07 Ventyx Biosciences, Inc. (VTYX) Delisted Sell (S) −26,472 -$863.3K EDGAR
2023-09-05 Ventyx Biosciences, Inc. (VTYX) Delisted Notice (144) −26,472 -$893.4K EDGAR
2023-07-26 Ventyx Biosciences, Inc. (VTYX) Delisted Mixed — -$898.4K EDGAR
2023-07-25 Ventyx Biosciences, Inc. (VTYX) Delisted Notice (144) −28,000 -$1.01M EDGAR
2023-06-07 Ventyx Biosciences, Inc. (VTYX) Delisted Mixed — -$873.4K EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.